We examined 214 patients from independent pedigrees with at least two CMM cases.

In the past, the CMM rented vessels from companies or fishermen.

These findings imply that the kynurenine pathway is pathologically relevant in patients with CMM.

The median thickness of CMMs at LLNL decreased faster than those from the comparison laboratory.

The goal of this study was to determine if CMM patients without visual symptoms also express anti-TRPM1 autoantibodies.